New York, NY -- (SBWIRE) -- 01/17/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today we bring special trend analysis of following stocks: Monster Worldwide, Inc. (NYSE:MWW), Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP).
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Monster Worldwide, Inc. (NYSE:MWW) stock moved down -2.81% and finished the day at $6.58, while its opening price was $6.74.The company traded with the total volume of 1.08 million shares, while its average trading volume remained 2.48 million shares. During the last one month it rose with the percentage of 10.96. Monster Worldwide, Inc., together with its subsidiaries, provides online and mobile employment solutions worldwide.
Has MWW Found The Bottom and Ready To Move Up? Find out Here
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) percentage change reduced -2.71% to close at $13.29 with the total traded volume of 1.07 million shares, and average volume of 918,942.00. The Company’s year to date performance remained optimistic with the rise of 7.09%. During last trade its minimum price was $13.16 and it gained its highest price of $14.08. Vanda Pharmaceuticals, Inc., a biopharmaceutical company, offers development and commercialization of products for the treatment of central nervous system disorders.
Has VNDA Found The Bottom And Ready To Gain Momentum? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) started its trading session with the price of $6.27 and closed at $6.17 by scoring -2.68%. The stocks traded with total volume of 1.92 million shares, while the average trading volume remained 2.38 million shares. Previous 5 days graph demonstrated a positive move of 8.63%. The 52-week price range of the stock remained $2.05 - $7.09. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Why Should Investors Buy MACK After the Recent Fall? Just Go Here and Find Out
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) during the previous trading session, the stock showed a negative movement of -2.62%. ZIOP traded with volume of 1.31 million shares, while its average trading volume remained 1.31 million shares. Stock’s closing price was $4.46 while it started its day-trade at $4.59. Its 52-week price range was $1.49 - $5.95. ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the discovery and development of new cancer therapies.
Will ZIOP Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets?
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the company’s profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)